Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction

We report a patient with HER2-positive metastatic adenocarcinoma of the GEJ who showed significant clinical and radiological benefit to HER2-directed therapy in the fifth-line therapeutic setting.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research